Biomedical subjects

T Rosenbaum

Publications and source records attributed to T Rosenbaum.

23 records · Page 2Linked to original sources

PubMed1995

Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.

To identify cell type(s) that might contribute to nerve sheath tumors (neurofibromas) in patients with neurofibromatosis type 1, we generated cell cultures containing neurons. Schwann cells and fibroblasts from transgenic mouse embryos in which the type 1 neurofibromatosis gene was disrupted by homologous recombination (Brannan et al. (1994) Genes Development, 8,1019-1029). Normal fascicle formation by perineurial cells failed to occur in the absence of neurofibromin. Fascicles were reduced in number and showed abnormal morphology when normal neurons and Schwann cells were cultured up to 37 days with fibroblasts lacking neurofibromin. Proliferation was increased in a majority of fibroblast cell strains analyzed from embryos lacking neurofibromin. These observations suggest that mutations in the neurofibromatosis type I gene affect fibroblast behavior that might contribute to neurofibroma formation in patients with neurofibromatosis type 1.

Animals↗

PubMed1993

Extended deep vein and inferior vena cava thrombosis in a 15-year-old boy: successful lysis with recombinant tissue-type plasminogen activator 2 weeks after onset of symptoms.

We present the case of a 15-year-old boy with thrombosis of the inferior vena cava, the femoral, inguinal, and renal veins of unknown origin. Although the thrombosis was 2 weeks old, thrombolytic therapy with recombinant tissue-type plasminogen activator (maximum dosage: 0.4 mg/kg/h) was started as this appeared to be the only change to re-establish normal kidney function. After 1 week, treatment was discontinued because of generalized bleeding. At this time, the infrarenal inferior vena cava was again patent with complete lysis of all other clots. Phlebography 3 months after lysis documented an abnormal renal vein, a tubular, subhepatical stenosis of the inferior vena cava and a large collateral vessel between the inferior vena cava and the azygos vein.

Adolescent↗

PubMed1990

Chronic dehydration stone disease.

A study was made of 819 patients attending a metabolic stone clinic. A firm diagnosis was made in 708 (86%) and in 132 of these (19%) the diagnosis was thought to be chronic dehydration. The records were available for study for 87 males and 11 females in the chronic dehydration group. The mean age at presentation was 43 years. The causes of chronic dehydration were hot climate (62%), with hot occupation and low water intake almost equal in second place. In patients with a single cause of chronic dehydration, 57% also had a dietary risk factor for urolithiasis and this was most commonly high oxalate intake. Following dietary advice, the mean urinary volume increased from 1720 to 2475 ml/24 h. This was accompanied by a rise in mean urinary calcium from 6.02 to 6.96 mmol/24 h, presumably due to the calcium in the additional water drunk. Urinary oxalate did not change significantly. The mean follow-up time was 4.85 years and the stone recurrence rate was low. It was concluded that chronic dehydration is a common cause of urolithiasis; this can be treated satisfactorily by increasing water intake plus dietary advice in certain cases.

Adult↗

PubMed1989

Beta-receptor-adenylate cyclase coupling in hypoxic neonatal rat ventricular myocytes.

This study investigated the influence of hypoxia on alterations in the beta-adrenergic receptor-adenylate cyclase system. Cultured neonatal rat ventricular myocytes were subjected to normoxia (incubator PO2 135-145 mmHg) or hypoxia (incubator PO2 0-14 mmHg) and, in crude membrane preparations, beta-receptor binding properties were measured with [125I]iodocyanopindolol and adenylate cyclase activity by radioimmunoassay. Hypoxia of 30 min in duration caused no alteration in beta-receptor density (Bmax 75 +/- 11 vs. 71 +/- 12 fmol/mg protein) but increased adenylate cyclase activity under basal conditions and during stimulation with l-isoproterenol, 5'-guanylimidotriphosphate [Gpp(NH)p] 5 X 10(-5) M, NaF 10(-4) M, and forskolin 10(-4) M. For example, isoproterenol 10(-5) M + guanosine 5'-triphosphate (GTP) 5 X 10(-5) M gave 221 +/- 34 vs. 143 +/- 11 pmol.min-1.mg protein-1, P less than 0.05 hypoxia vs. normoxia. After 60 min of hypoxia, adenylate cyclase activity was no longer increased. Hypoxia of 120-150 min duration increased Bmax by 64% (73 +/- 8 to 120 +/- 11 fmol/mg protein, P less than 0.05 vs. normoxia) but decreased adenylate cyclase activity during stimulation with isoproterenol, NaF 10(-4) M, and forskolin 10(-4) M. For example, isoproterenol 10(-5) M + GTP 5 X 10(-5) M gave 107 +/- 12 vs. 148 +/- 11 pmol.min-1.mg protein-1, P less than 0.05 hypoxia vs. normoxia. Reoxygenation for 15 min following 120-150 min of hypoxia reversed the increased beta-receptor numbers and decreased adenylate cyclase activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Adenylyl Cyclases↗

PubMed1985

Characterization of a potentially reversible increase in beta-adrenergic receptors in isolated, neonatal rat cardiac myocytes with impaired energy metabolism.

Previous studies have reported that the numbers of beta- and alpha-adrenergic receptors increase in ischemic myocardium. In vivo studies have raised questions regarding the mechanisms involved in the adrenergic receptor alterations and the consequences of these alterations. The purpose of this study was to evaluate potential relationships among beta-adrenergic receptor changes, high energy phosphate reduction, and severity of cell injury in cultured neonatal rat myocytes treated with metabolic inhibitors. The potential for reversal of the receptor changes also was addressed. Binding parameters were measured using [125I]iodocyanopindolol. After 4 hours incubation in potassium cyanide and 2-deoxyglucose, there was a 43% increase in beta-adrenergic receptor number, 41% decrease in adenosine triphosphate, and minimal morphological change in myocytes. Twenty-four hours after removal of the inhibitors, myocytes exhibited a return to normal of the receptor number and adenosine triphosphate level. Iodoacetate treatment for up to 3 hours resulted in marked reduction in adenosine triphosphate and increasing severity of cell injury. The number of beta-adrenergic receptors was unchanged at 1.2 hours, increased at 1.5-2 hours, and decreased at 3 hours. Thus: beta-adrenergic receptor density increases during relatively early stages of injury in metabolically impaired myocytes with reduced adenosine triphosphate levels and decreases subsequently, after the myocytes become irreversibly injured; the increased beta-adrenergic receptor density in moderately injured myocytes can be reversed upon removal of the injurious agent and restoration of the cellular adenosine triphosphate level; and changes in catecholamines mediated by an intact nervous system are not required for an increase in beta-adrenergic receptor density in the setting of impaired energy metabolism.

Adenosine Triphosphate↗